|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:ATCCode
|
L01AX03
|
|
gptkbp:CASNumber
|
85622-93-1
|
|
gptkbp:hasInChIKey
|
TZIKCAFNXDKGEX-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C6H6N6O2
|
|
gptkbp:hasPatentExpiry
|
2013 (US)
|
|
gptkbp:hasSMILES
|
CN(C)C(=O)N1C=NC2=NC=NN21
|
|
gptkbp:hasTherapeuticUse
|
treatment of anaplastic astrocytoma
treatment of glioblastoma
|
|
gptkbp:hasUNII
|
J41CSQ7QDS
|
|
gptkbp:KEGGID
|
D06053
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
gptkb:antineoplastic_agent
|
|
gptkbp:meltingPoint
|
212-214°C
|
|
gptkbp:molecularWeight
|
194.15 g/mol
|
|
gptkbp:name
|
gptkb:Temozolomide
|
|
gptkbp:pregnancyCategory
|
D (US)
|
|
gptkbp:PubChem_CID
|
5394
CHEMBL177
DB00853
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
vomiting
fatigue
myelosuppression
|
|
gptkbp:status
|
FDA approved
EMA approved
|
|
gptkbp:synonym
|
gptkb:NSC_362856
gptkb:SCH_52365
gptkb:Temodal
gptkb:Temodar
gptkb:Temozolomideum
CCRG 81045
|
|
gptkbp:bfsParent
|
gptkb:Safrole
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
C10483
|